Friday, June 27, 2025 6/27/2025

ROLE OF SRC FAMILY KINASES IN ENDOTHELIAL CELL BIOLOGY

Award Number: R01HL073396
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2002
PERIOD OF PERFORMANCE END DATE: 01/31/2012

Group Awards By:

View Award Description

ROLE OF SRC FAMILY KINASES IN ENDOTHELIAL CELL BIOLOGY - DESCRIPTION (provided by applicant): The endothelial barrier of the brain is characterized by specialized endothelial cells with low paracellular permeability. Along with the basement membrane and other cell types, the blood brain barrier (BBB) is an important regulator of normal brain metabolism. VEGF is a growth factor secreted by tumors that can induce vascular permeability (VP) and disrupt the integrity of the BBB. Our previous studies have demonstrated a Src requirement in the host compartment for VEGF-induced vascular permeability (VP), particularly in the lung and brain. We have exploited the 'leakage-resistant1 phenotype of Src-knockout mice to examine the characteristics of tumor growth and metastasis. These studies have revealed that an absence of Src leads to reduced VEGF-induced VP of blood vessels providing protection from lung metastases. In the brain, a reduction in VEGF-induced VP has also been associated with Src-mediated changes in FAK phosphorylation. Recent data indicate that FAK is enriched in brain blood vessels compared to surrounding cell types, and is a target of Src-mediated VP. We hypothesize that FAK is a key intermediate in the maintenance of the integrity of the BBB. In Aim 1 we will characterize the role of Src in regulating VEGF- induced FAK activation and VP of brain blood vessels. These studies will examine the molecular basis for the VP phenotype and will include the characterization of BMK1 and eNOS. In Aim 2 we will determine whether Src regulates BMK1 in VEGF-stimulated brain blood vessels. In Aim 3 we will examine the role of eNOS in Src- vs. BMK1-mediated VEGF-induced VP. While these studies will provide novel and important insights into the regulation of the BBB, relatively few studies have examined the role of the BBB in tumor metastasis. Therefore, we will use animal models to determine the function of FAK, BMK1 and eNOS in the host compartment during breast tumor metastasis to the brain. These studies will build upon our previous studies of the role of Src in the host compartment in Src-mediated metastases to the lung and provide a comparison for the characterization of the growth and invasion of intracranial tumors. A panel of human astrocytomas is available for xenograft mouse models of human glioma growth and infiltration. The results of these studies will be validated in human brain tumor samples of varying malignancy to determine the clinicopathological relevance of VP and the BBB in various stages of tumor growth and invasion.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2011 ( Subtotal = $347,625 )
2011	2011	UNIVERSITY OF CALIFORNIA-SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	000	10	1/21/2011	NON-COMPETING CONTINUATION	$347,625
														Subtotal = $347,625

Issue Date FY: 2010 ( Subtotal = $347,625 )
2010	2010	UNIVERSITY OF CALIFORNIA-SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	000	9	1/13/2010	NON-COMPETING CONTINUATION	$347,625
														Subtotal = $347,625

Issue Date FY: 2009 ( Subtotal = $347,625 )
2009	2009	UNIVERSITY OF CALIFORNIA-SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	001	8	1/26/2009	NON-COMPETING CONTINUATION	$0
2009	2009	UNIVERSITY OF CALIFORNIA-SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	000	8	1/5/2009	NON-COMPETING CONTINUATION	$347,625
														Subtotal = $347,625

Issue Date FY: 2008 ( Subtotal = $347,625 )
2008	2008	UNIVERSITY OF CALIFORNIA-SAN DIEGO	9500 GILMAN DRIVE	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	000	7	2/11/2008	NON-COMPETING CONTINUATION	$347,625
														Subtotal = $347,625

Issue Date FY: 2007 ( Subtotal = $491,175 )
2007	2007	LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE	4570 EXECUTIVE DR, SUITE 100	SAN DIEGO	CA	92121	SAN DIEGO	USA	Cardiovascular Diseases Research	000	5	1/23/2007	COMPETING CONTINUATION	$491,175
														Subtotal = $491,175

Issue Date FY: 2005 ( Subtotal = $414,600 )
2005	2005	LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE	4570 EXECUTIVE DR, SUITE 100	SAN DIEGO	CA	92121	SAN DIEGO	USA	Cardiovascular Diseases Research	000	4	6/29/2005	NON-COMPETING CONTINUATION	$414,600
														Subtotal = $414,600

Issue Date FY: 2004 ( Subtotal = $414,600 )
2004	2004	LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE	4570 EXECUTIVE DR, SUITE 100	SAN DIEGO	CA	92121	SAN DIEGO	USA	Cardiovascular Diseases Research	000	3	6/17/2004	NON-COMPETING CONTINUATION	$414,600
														Subtotal = $414,600

Issue Date FY: 2003 ( Subtotal = $414,600 )
2003	2003	LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE	4570 EXECUTIVE DR, SUITE 100	SAN DIEGO	CA	92121	SAN DIEGO	USA	Cardiovascular Diseases Research	000	2	8/4/2003	NON-COMPETING CONTINUATION	$414,600
														Subtotal = $414,600

Issue Date FY: 2002 ( Subtotal = $414,600 )
2002	2002	LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE	4570 EXECUTIVE DR, SUITE 100	SAN DIEGO	CA	92121	SAN DIEGO	USA	Cardiovascular Diseases Research	000	1	7/31/2002	NEW	$414,600
														Subtotal = $414,600

Grand Total All Awards = $3,540,075

Top

All Categories

About

Search

Reports

Data Submission

Award Information

ROLE OF SRC FAMILY KINASES IN ENDOTHELIAL CELL BIOLOGY

Award Number: R01HL073396

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2002

PERIOD OF PERFORMANCE END DATE: 01/31/2012

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer